» Authors » Toru Miyoshi

Toru Miyoshi

Explore the profile of Toru Miyoshi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 274
Citations 2585
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yunoki K, Matsumi H, Miyoshi T, Kubo M, Hata Y, Yuasa S
J Cardiovasc Dev Dis . 2025 Feb; 12(2). PMID: 39997494
Methods: A total of 150 consecutive patients with CAD receiving statin therapy (LDL-C levels < 100 mg/dL) were enrolled. Serum omega-3 fatty acid levels were measured, and endothelial function was...
2.
Seiyama K, Oka A, Miyoshi T, Sudo Y, Takagi W, Ugawa S, et al.
Circ Rep . 2025 Feb; 7(2):131-138. PMID: 39931715
Background: Intensive lipid-lowering therapy (ILLT) is crucial for preventing secondary acute coronary syndrome (ACS). However, achieving target low-density lipoprotein cholesterol (LDL-C) levels remains challenging in clinical practice. Methods And Results:...
3.
Takaya Y, Nakagawa K, Miyoshi T, Nishii N, Morita H, Nakamura K, et al.
Circ J . 2025 Feb; PMID: 39924247
Background: The prognostic utility of high-sensitivity cardiac troponin T (hs-cTnT) on clinical outcomes in cardiac sarcoidosis (CS) remains unknown, so we evaluated hs-cTnT in the chronic phase of CS. Methods...
4.
Nishihara T, Miyoshi T, Ejiri K, Osawa K, Fuke S, Seiyama K, et al.
JACC Asia . 2025 Jan; 5(1):1-11. PMID: 39886202
Background: Pericoronary adipose tissue attenuation (PCATA) is a novel imaging biomarker of pericoronary inflammation associated with coronary artery disease. Several studies have reported the usefulness of PCATA among people of...
5.
Vo Q, Nakamura K, Saito Y, Iida T, Yoshida M, Amioka N, et al.
Cells . 2025 Jan; 13(24. PMID: 39768137
Induced pluripotent stem cell (iPSC)-derived biological pacemakers have emerged as an alternative to traditional electronic pacemakers for managing cardiac arrhythmias. While effective, electronic pacemakers face challenges such as device failure,...
6.
Nishikawa T, Higaki A, Kurokawa K, Yoshimoto K, Horie R, Nakao Y, et al.
In Vivo . 2024 Dec; 39(1):375-380. PMID: 39740918
Background/aim: Imeglimin, a novel oral antidiabetic agent, was approved in 2021 for the treatment of type 2 diabetes mellitus (T2DM). Phase III clinical trials demonstrated its safety and efficacy in...
7.
Konishi R, Higaki A, Miyoshi T, Nishimura K, Ikeda S, Yamaguchi O
Oxf Med Case Reports . 2024 Dec; 2024(12):omae156. PMID: 39734689
An 82-year-old woman with a history of myocardial infarction presented with worsening effort angina. Coronary angiography (CAG) revealed 75% stenosis in the proximal left anterior descending artery (LAD), with intravascular...
8.
Fujisawa T, Kawakami H, Tamaki S, Miyazaki S, Akazawa Y, Miyoshi T, et al.
Heart Vessels . 2024 Dec; PMID: 39674957
The relationship between post-ablation excessive supraventricular ectopic activity (ESVEA), a new marker for new-onset atrial fibrillation (AF), and late AF recurrence is uncertain. We enrolled 469 patients with AF who...
9.
Takaya Y, Nakagawa K, Miyoshi T, Nishii N, Morita H, Nakamura K, et al.
Am J Cardiol . 2024 Dec; 238:65-69. PMID: 39653305
Although isolated cardiac sarcoidosis (CS) is not uncommon, little is known about the risk of life-threatening ventricular tachyarrhythmia. We aimed to evaluate the incidence of ventricular tachyarrhythmia in patients with...
10.
Miyoshi T, Shinozuka F, Honda T, Akazawa Y, Yamaguchi O
Cureus . 2024 Nov; 16(10):e72231. PMID: 39583506
A male in his seventies was admitted for a patent ductus arteriosus (PDA) closure. We planned a catheter-based closure but avoided pre-procedural contrast-enhanced CT due to his low estimated glomerular...